ALPS ADVISORS INC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2023$571,676
-23.0%
148,874
-0.5%
0.01%
-28.6%
Q4 2022$742,214
+28.9%
149,640
+24.2%
0.01%
+40.0%
Q3 2022$576,000
-2.2%
120,468
-7.9%
0.01%
-16.7%
Q2 2022$589,000
-45.4%
130,820
-42.3%
0.01%
-50.0%
Q1 2022$1,079,000
-41.3%
226,649
-8.5%
0.01%
-42.9%
Q4 2021$1,838,000
+27.3%
247,759
-2.7%
0.02%
+50.0%
Q3 2021$1,444,000
-16.8%
254,742
-3.3%
0.01%
-6.7%
Q2 2021$1,736,000
+116.7%
263,357
+18.3%
0.02%
+25.0%
Q3 2020$801,000
-26.8%
222,588
-6.4%
0.01%
-20.0%
Q2 2020$1,094,000
+2.3%
237,910
-24.1%
0.02%
-11.8%
Q1 2020$1,069,000
-31.1%
313,413
+3.1%
0.02%
+41.7%
Q4 2019$1,551,000
+114.5%
303,888
+1.7%
0.01%
+100.0%
Q3 2019$723,000
+6.5%
298,881
-4.5%
0.01%
+20.0%
Q2 2019$679,000
-30.4%
312,992
-13.1%
0.01%
-28.6%
Q1 2019$976,000
-41.0%
360,111
+4.5%
0.01%
-46.2%
Q4 2018$1,654,000
-33.8%
344,561
+30.7%
0.01%
-18.8%
Q3 2018$2,497,000
+32.9%
263,711
+36.6%
0.02%
+33.3%
Q2 2018$1,879,000
+0.7%
193,071
+8.8%
0.01%
-20.0%
Q1 2018$1,866,000
+98.7%
177,378
+21.0%
0.02%
+114.3%
Q4 2017$939,000
+12.6%
146,549
+49.7%
0.01%
-22.2%
Q1 2016$834,000
-46.4%
97,910
-14.6%
0.01%
-40.0%
Q4 2015$1,555,000
-88.0%
114,590
-15.1%
0.02%
+7.1%
Q3 2015$12,950,000
+952.8%
134,900
+57.7%
0.01%
+40.0%
Q2 2015$1,230,000
+221.1%
85,536
+99.9%
0.01%
+233.3%
Q1 2015$383,00042,7840.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2021
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders